19,854
Total Claims
$1.7M
Drug Cost
1,078
Beneficiaries
$1,535
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+1%
Cost per patient vs peers
$1,535 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 17,676 claims · $414K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 473 | $409K |
| Sitagliptin Phosphate | 150 | $167K |
| Rivaroxaban | 113 | $108K |
| Empagliflozin | 79 | $78K |
| Sitagliptin Phos/Metformin Hcl | 52 | $68K |
| Levothyroxine Sodium | 500 | $57K |
| Dapagliflozin Propanediol | 59 | $55K |
| Candesartan Cilexetil | 351 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 50 | $44K |
| Ticagrelor | 47 | $42K |
| Metoprolol Succinate | 1,228 | $33K |
| Linagliptin | 27 | $33K |
| Losartan Potassium | 1,477 | $31K |
| Candesartan/Hydrochlorothiazid | 109 | $27K |
| Sacubitril/Valsartan | 26 | $24K |
Prescribing Profile
94
Unique Drugs
$841K
Patient Profile
76
Avg Age
62%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data